Investment Summary

1315 Capital Invests In Primrose Bio

On June 17, 2024, growth capital firm 1315 Capital invested in life science company Primrose Bio

Investment Highlights
  • This is 1315 Capital’s 5th transaction in the Life Science sector.
  • This is 1315 Capital’s 18th transaction in the United States.
  • This is 1315 Capital’s 6th transaction in California.

Investment Summary
Date 2024-06-17
Target Primrose Bio
Sector Life Science
Investor(s) 1315 Capital
Deal Type Growth Capital

Target

Primrose Bio

San Diego, California, United States
Primrose Bio is a company focused on developing and licensing its manufacturing technologies for nucleic acids and proteins used in therapeutics and vaccines. Primrose Bio is based in San Diego, California.

Search 202,137 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

1315 Capital

Investor Investor Investor Investor Investor

Category Growth Capital Firm
Founded 2014
Size Small
Type Sector Focused
DESCRIPTION

1315 Capital is a private investment firm that provides expansion and growth capital to commercial-stage specialty pharmaceutical, medical technology, and healthcare service companies. The Firm will consider opportunities across the US and generally looks to commit $10 to $40 million per investment. 1315 Capital was formed in 2014 and is based in Philadelphia, Pennsylvania.

DEAL STATS #
Overall 20 of 21
Sector (Life Science) 5 of 6
Type (Growth Capital) 6 of 6
State (California) 6 of 6
Country (United States) 18 of 19
Year (2024) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-01-09 Verogen

San Diego, California, United States

Verogen is a developer, manufacturer, and sells forensic genomics products and services, including for next-generation sequencing. Verogen was formed in 2017 and is based in San Diego, California.

Sell $150M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-11-12 SciSafe

Cranbury, New Jersey, United States

SciSafe is a provider of biological materials storage to the cell and gene therapy and pharmaceutical industries. SciSafe was established in 2010 and is based in Cranbury, New Jersey.

Buy $73M
Mergr

Product

Company

Legal